4BIO Capital Co-leads $10 Million Seed Financing in Code Biotherapeutics
20 avr. 2021 09h00 HE
|
4Bio Capital
Press Release 4BIO Capital Co-leads $10 Million Seed Financing in Code Biotherapeutics 20 April 2021 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital...
4BIO Capital Joins Investor Syndicate in CARISMA Therapeutics’ Second Closing of $59 Million Series B Round
01 mars 2021 08h08 HE
|
4Bio Capital
Press Release 4BIO Capital Joins Investor Syndicate in CARISMA Therapeutics’ Second Closing of $59 Million Series B Round 1 March 2021 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”),...
4BIO Capital’s review of AAV gene therapy clinical trials published in Nature Reviews Drug Discovery
25 janv. 2021 07h00 HE
|
4Bio Capital
Press Release 4BIO Capital’s review of AAV gene therapy clinical trials published in Nature Reviews Drug Discovery Systematic review and meta-analysis of 149 clinical trials of AAV-based gene...
Appointment of Professor Akiko Iwasaki to Scientific Advisory Board
18 déc. 2020 07h00 HE
|
4Bio Capital
Appointment of Professor Akiko Iwasaki to Scientific Advisory Board Professor of Molecular, Cellular and Developmental Biology and Immunology at Yale UniversityPrincipal investigator at the Howard...
Appointment of Professor Akiko Iwasaki to Scientific Advisory Board
18 déc. 2020 02h00 HE
|
4Bio Capital
Appointment of Professor Akiko Iwasaki to Scientific Advisory Board Professor of Molecular, Cellular and Developmental Biology and Immunology at Yale UniversityPrincipal investigator at the Howard...
4BIO Capital leads SparingVision’s €44.5 million financing round
21 oct. 2020 07h00 HE
|
4Bio Capital
Press Release 4BIO Capital leads SparingVision’s €44.5 million financing round 21 October 2020 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm...
4BIO Capital leads SparingVision’s €44.5 million financing round
21 oct. 2020 01h00 HE
|
4Bio Capital
Press Release 4BIO Capital leads SparingVision’s €44.5 million financing round 21 October 2020 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm...
4BIO Capital announces appointment of Professor Kenya Honda to Scientific Advisory Board
13 juil. 2020 07h00 HE
|
4Bio Capital
4BIO Capital announces appointment of Professor Kenya Honda to Scientific Advisory Board Professor of Microbiology and Immunology at Keio UniversityBrings extensive experience in gut microbiota, a...
4BIO Capital announces appointment of Professor Kenya Honda to Scientific Advisory Board
13 juil. 2020 02h00 HE
|
4Bio Capital
4BIO Capital announces appointment of Professor Kenya Honda to Scientific Advisory Board Professor of Microbiology and Immunology at Keio UniversityBrings extensive experience in gut microbiota, a...
4BIO Capital appoints Brian P. McVeigh as Venture Partner
01 juil. 2020 07h00 HE
|
4Bio Capital
Press Release 4BIO Capital appoints Brian P. McVeigh as Venture Partner Appointment of seasoned pharma and biotech industry veteran to strengthen 4BIO Capital’s US operations 1 July 2020 LONDON...